A detailed history of Point72 Hong Kong LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Point72 Hong Kong LTD holds 120,836 shares of ABBV stock, worth $28.3 Million. This represents 1.68% of its overall portfolio holdings.

Number of Shares
120,836
Holding current value
$28.3 Million
% of portfolio
1.68%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$170.16 - $206.27 $20.6 Million - $24.9 Million
120,836 New
120,836 $22.4 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $12.5 Million - $14.1 Million
90,858 New
90,858 $14.1 Million
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $5.67 Million - $7.21 Million
-41,184 Reduced 77.01%
12,293 $1.88 Million
Q1 2022

May 16, 2022

BUY
$131.98 - $163.75 $827,646 - $1.03 Million
6,271 Added 13.28%
53,477 $8.67 Million
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $4.45 Million - $5.63 Million
-41,420 Reduced 46.74%
47,206 $6.39 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $4.01 Million - $4.55 Million
37,661 Added 73.9%
88,626 $9.56 Million
Q1 2021

May 17, 2021

SELL
$102.3 - $112.62 $1.59 Million - $1.76 Million
-15,584 Reduced 23.42%
50,965 $5.52 Million
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $5.36 Million - $7.23 Million
66,549 New
66,549 $7.13 Million
Q1 2020

May 15, 2020

SELL
$64.5 - $97.79 $418,669 - $634,754
-6,491 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $468,195 - $585,812
6,491 New
6,491 $575,000
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $526,421 - $649,219
-6,762 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$88.91 - $98.84 $601,209 - $668,356
6,762 New
6,762 $640,000
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $418,464 - $495,138
-4,661 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$92.01 - $123.21 $428,122 - $573,296
4,653 Added 58162.5%
4,661 $441,000
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $151,087 - $165,680
-1,687 Reduced 99.53%
8 $1,000
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $118,395 - $151,227
1,695
1,695 $151,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $414B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.